GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Advaxis, Inc. (ADXS) [hlAlert]

Advaxis, Inc. is a development-stage biotechnology company with the focus on developing cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania (Penn), which
secretes a protein sequence containing a tumor-specific antigen. This technology involves the creation of genetically engineered Listeria that stimulates the innate immune system and induces an antigen-specific immune response involving both arms of the adaptive immune system. The Company?s products in development are ADXS11-001, ADXS31-142 and ADXS31-164. The Company uses genetically engineered and attenuated Listeria monocytogenes as a therapeutic agent. The Company?s agent ADX11-001, uses a human papilloma virus (HPV) derived antigen that is present in cervical cancers.
.
( Total: 6 Current Stock Recommendations )
Advaxis, Inc.   (6)
Buy 100%
Related companies
Filter by Gains:   
  
Rating:
Buy ADXS
down 6.02 %

Rating:
Buy ADXS
down 21.45 %

Rating:
Buy ADXS
down 23.62 %
Advaxis, Inc. (ADXS) rated Buy with price target $34 by MLV & Co
Thursday,  May 14, 2015  8:25 AM ET

Rating:
Buy ADXS
up 378.27 %

Rating:
Buy ADXS
up 163.09 %

Rating:
Buy ADXS
up 201.20 %

Your Recent Stocks
SymbolLastChange
ADXS 7.54 down  -49.63 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy